News

Clinical Drug Trials: Black Patients Are Needed


 

“And the consequences have been awful. For example, once the second-generation antipsychotic medications came on the market it became clear that the risk of obesity, diabetes, and metabolic syndrome was much more of a problem for African Americans and Hispanics than for whites. We don't want to improve the mental health of our patients at the expense of giving them complications that can be lethal,” Dr. Lawson said.

Pages

Recommended Reading

Congress Floats Medicare Payment Formula Fixes
MDedge Psychiatry
Policy & Practice
MDedge Psychiatry
Medicare Won't Accept Paper Claims as of Oct. 1 : Rules exclude practices with fewer than 10 full-time employees and institutions with fewer than 25.
MDedge Psychiatry
Develop a Proactive HIPAA Complaint Process, Lawyer Advises
MDedge Psychiatry
Think Tank Wants Parity–and More
MDedge Psychiatry
Can Physicians Improve Patients' Health Literacy?
MDedge Psychiatry
Cost-Saving Alternatives Offered for Medicaid Program
MDedge Psychiatry
Prepare Now for Launch of Medicare Part D Benefit in January
MDedge Psychiatry
Doctors Share Their Weight Loss Struggles
MDedge Psychiatry
Feds Push for Electronic Health Record System
MDedge Psychiatry